This analysis revealed that SF3B1 and XPO1 mutations had the highest relative impact on TTFT in M-CLL and SF3B1 and TP53 aberrations in U-CLL (Supplementary Fig. 7). The gene discussed is SF3B1; the disease is B-cell chronic lymphocytic leukemia.